A Chinese drug company executive was sentenced to prison in a U.S. court for importing a fentanyl analogue

A Chinese national who held executive positions at Chinese chemical and pharmaceutical companies was sentenced Wednesday (Jan. 13) to 28 months in prison on drug and money laundering charges, including importing fentanyl analogs into New Jersey, U.S. Justice Department officials announced.

According to court documents, Hao Qin (also known as John Qin), 34, of Shanghai, China, was convicted of importing more than 500 kilograms of controlled substance analogs into the U.S. The controlled substances he and his associates imported through their chemical business included furanyl fentanyl and 4-FIBF, two analogs of the powerful opioid drug fentanyl.

The Justice Department said Qin Hao also laundered proceeds from his international drug business, including receiving $500,000 in remittances that he owed to a former customer in the United States for drug purchases.

In addition to serving time in prison, a federal district judge in New Jersey sentenced him to three years of supervised release, which means he will be under the supervision of authorities for three years after his release from prison.

Qin Hao was arrested last May 21 after arriving at Los Angeles International Airport. The U.S. Department of Justice has not released which chemical or drug companies are linked to him.